Glaucoma UK was accepting applications from clinical and non-clinical researchers for the Open Call Research Award 2024, ...

Glaukos Corporation GKOS reported first-quarter 2024 adjusted loss of 70 cents per share, which is 20.7% wider than the Zacks ...

Glaucoma is a group of eye diseases that can cause vision loss due to damage to the optic nerve, which transmits visual signals from the eye to the brain. Your eyes regularly make a fluid-like ...

Rick Lewis, chief medical officer of ViaLase, describes the company's nonincisional glaucoma treatment, showing promising ...

Both macular degeneration and glaucoma can lead to vision loss and blindness. But they have different causes and treatments. Age-related macular degeneration (AMD) and glaucoma are two of the most ...

Dr Akhilesh Sharma shared, “For screening of normal individuals for glaucoma since glaucoma does not present with any early ...

Understanding the specific type of Glaucoma is essential for tailoring an effective treatment plan, as the underlying causes ...

As the global population living with glaucoma surpasses 70 million, with over six million individuals blind from the ...

A team led by University of Pennsylvania scientists has discovered three genetic variants that offer the first strong clues as to why glaucoma disproportionately affects Black people. The variants ...

Although the pathogenesis of NTG remains uncertain, the bulk of evidence points to a chronic progressive ischemic disorder with hypoperfusion of the optic nerve head as a mechanism of the disorder ...

Diseases are bad news, and when one has gained notoriety like the way glaucoma is prevalent in Ghana, it calls for a lot of ...

Qlaris Bio, Inc. (“Qlaris”), a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced that it has closed a $24 million Series B financing round ...